Table 2.
Variables | Log-transformed glucose infusion rate | |
---|---|---|
R | P-value | |
Age, years | 0.38 | 0.10 |
BMI, kg/m2 | −0.35 | 0.13 |
Skeletal muscle mass, kg | −0.42 | 0.066 |
Fat mass, kg | −0.01 | 0.97 |
HbA1c (NGSP, %; IFCC, mmol/mol) | −0.10 | 0.67 |
Fasting plasma glucose concentration, mmol/L | −0.22 | 0.36 |
HOMA-IR value | −0.59 | 0.0063a |
Urinary glucose excretion, g/day | −0.06 | 0.79 |
Aspartate transaminase, IU/L | −0.52 | 0.019a |
Alanine transaminase, IU/L | −0.64 | 0.0025a |
Serum uric acid, μmol/L | 0.05 | 0.84 |
HDL-cholesterol, mmol/L | 0.16 | 0.50 |
Triglyceride, mmol/L | −0.02 | 0.93 |
LDL-cholesterol, mmol/L | −0.23 | 0.33 |
Statistical significance was determined via Pearson’s correlation coefficient. Values in bold a indicate P < 0.05.
HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; IFCC, International Federation of Clinical Chemistry and Laboratory Medicine; LDL, low-density lipoprotein; NGSP, National Glycohemoglobin Standardization Program.